Skip to main content
. 2022 Nov 11;48(4):439–459. doi: 10.1007/s10867-022-09618-8

Table 2.

Parameter, description, value (unit), and references

Parameter Description Value (unit) Reference
αT Glioma growth rate 1.575 (ml2 g−1 day−1) [39, 40]
KT Glioma carrying capacity 2 (g ml−1) [41]
dTI The degradation rate of glioma due to immune response 0.072 (day−1) [5]
αTI The recruitment rate of the immune cell due to glioma 0.0003 (day−1) [5]
dT The natural degradation rate of glioma 0.0001(day−1) [42]
dI The natural degradation rate of immune cell 0.01 (day−1) [5]
αs The recruitment rate of immune cell 0.7 (day−1) [5]
v Production rate of glioma 0.7 (day−1) [5]
dTσ Glucose consumption rate by glioma 1 (day−1) [5]
ασ The glucose transfer rate from serum to brain 20 (day−1) [5]
dσ1 Glucose consumption of healthy cell 0.01 (g ml−1) [43]
dσ2 Glucose consumption metabolism 0.00625 (g ml−1) [43]
dTT Killing rate of glioma to immune cell 0.072 (g ml−1) [43]
KT Killing rate of a chemotherapy agent for glioma 0.01 (day−1) [44]
k Rate of drug resistance 4.04 × 103 (mg−1) [45]
β Rate of virus infections 2 × 104 (ml g−1 day−1) [46]
s Rate of Immune cells stimulated by virus 0.15 (ml g−1 day−1) [46]
KI Killing rate of a chemotherapy agent to immune cells 0.6 (day−1) [13]
dITi The natural death rate of immune cells responsible for the infection 0.1 (day−1) [41]
dTiI The natural death rate of immune cell response to infection 4.8 × 10−2(ml g−1 day−1) [42]
IN Normalized insulin concentrations 7.2 [43]
GN Normalized glucose concentrations 1.7647 [43]
rB The basal rate of glucose uptake 0.35 (g min−1) [43]
PBF Peripheral blood flow 900 (ml min−1) [44]
P(t) Injected chemotherapy agent 40–50 (mg kg−1) [45]
U(t) Injected virus 5 × 10−7 (g ml−1) [46]
dQ The degradation rate of the chemotherapy agent 2.5 (day−1) [45]
b Burst size 150 × 10−6 [46]
dTi The natural death rate of infected glioma 0.2 (day−1) [46]
ρ The loss rate of the virus during infection 4 × 10−2 (ml g−1 day−1) [46]